Yasuo Hamamoto

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 7

Top Venues

JCO precision oncology

Future oncology (London, England)

Japanese journal of clinical oncology

Diagnostics (Basel, Switzerland)

Keio University School of Medicine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Keio University School of Medicine Jul 01 2011

Japan

Associatetd Professor :: Cancer Center

Publications

Yoshiaki Nakamura, Riu Yamashita, Wataru Okamoto, Yoshito Komatsu, Satoshi Yuki, Makoto Ueno, Ken Kato, Hiroya Taniguchi, Yoshinori Kagawa, Tadamichi Denda, Hiroki Hara, Taito Esaki, Toshikazu Moriwaki, Yu Sunakawa, Eiji Oki, Fumio Nagashima, Tomohiro Nishina, Taroh Satoh, Hiasto Kawakami, Kensei Yamaguchi, Koushiro Ohtsubo, Takeshi Kato, Yosuke Horita, Akihito Tsuji, Hisateru Yasui, Masahiro Goto, Yasuo Hamamoto, Masashi Wakabayashi, Takashi Ikeno, Kohei Shitara, Hideaki Bando, Katsuya Tsuchihara, Izumi Miki, Hiroko Ichiki, Atsushi Ohtsu, Takayuki Yoshino
Efficacy of Targeted Trials and Signaling Pathway Landscape in Advanced Gastrointestinal Cancers From SCRUM-Japan GI-SCREEN: A Nationwide Genomic Profiling Program. JCO precision oncology 7 (2023)
Morihito Okada, Ken Kato, Byoung Chul Cho, Masanobu Takahashi, Chen-Yuan Lin, Keisho Chin, Shigenori Kadowaki, Myung-Ju Ahn, Yasuo Hamamoto, Yuichiro Doki, Chueh-Chuan Yen, Yutaro Kubota, Sung-Bae Kim, Chih-Hung Hsu, Eva Holtved, Ioannis Xynos, Yasuhiro Matsumura, Akira Takazawa, Yuko Kitagawa
Three-Year Follow-Up and Response-Survival Relationship of Nivolumab in Previously Treated Patients with Advanced Esophageal Squamous Cell Carcinoma (ATTRACTION-3). Clinical cancer research : an official journal of the American Association for Cancer Research 28 (15) (2022)
Yasuo Hamamoto, Kentaro Murakami, Ken Kato, Yuko Kitagawa
Management of elderly patients with esophageal squamous cell cancer. Japanese journal of clinical oncology 52 (8) (2022)
Masashi Takeuchi, Chiyo K Imamura, Eisuke Booka, Hiroya Takeuchi, Takuro Mizukami, Takeshi Kawakami, Taro Funakoshi, Kazushige Wakuda, Yu Aoki, Yasuo Hamamoto, Minoru Kitago, Hirofumi Kawakubo, Narikazu Boku, Yusuke Tanigawara, Yuko Kitagawa
Prospective evaluation and refinement of an S-1 dosage formula based on renal function for clinical application. Cancer science 112 (2) (2021)
Keitaro Shimozaki, Yasutaka Sukawa, Yasunori Sato, Sara Horie, Akihiko Chida, Kai Tsugaru, Kazuhiro Togasaki, Kenta Kawasaki, Kenro Hirata, Hideyuki Hayashi, Yasuo Hamamoto, Takanori Kanai
Analysis of risk factors for immune-related adverse events in various solid tumors using real-world data. Future oncology (London, England) 17 (20) (2021)
Keitaro Shimozaki, Kenro Hirata, Sara Horie, Akihiko Chida, Kai Tsugaru, Yukie Hayashi, Kenta Kawasaki, Ryoichi Miyanaga, Hideyuki Hayashi, Ryuichi Mizuno, Takeru Funakoshi, Naoki Hosoe, Yasuo Hamamoto, Takanori Kanai
The Entire Intestinal Tract Surveillance Using Capsule Endoscopy after Immune Checkpoint Inhibitor Administration: A Prospective Observational Study. Diagnostics (Basel, Switzerland) 11 (3) (2021)
Yasuo Hamamoto, Naoki Sakakibara, Fumio Nagashima, Yuko Kitagawa, Takahiro Higashi
Treatment selection for esophageal cancer: evaluation from a nationwide database. Esophagus : official journal of the Japan Esophageal Society 15 (2) (2018)

Yasuo Hamamoto.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yasuo Hamamoto